TOP > 外国特許検索 > Method for promoting immune response comprising inhibiting CD22 function in B cells

Method for promoting immune response comprising inhibiting CD22 function in B cells

外国特許コード F110003467
整理番号 A261-09WO
掲載日 2011年6月27日
出願国 アメリカ合衆国
出願番号 51613407
公報番号 20100063130
公報番号 9018245
出願日 平成19年12月21日(2007.12.21)
公報発行日 平成22年3月11日(2010.3.11)
公報発行日 平成27年4月28日(2015.4.28)
国際出願番号 JP2007074634
国際公開番号 WO2008078673
国際出願日 平成19年12月21日(2007.12.21)
国際公開日 平成20年7月3日(2008.7.3)
優先権データ
  • 特願2006-349458 (2006.12.26) JP
  • 2007WO-JP74634 (2007.12.21) WO
発明の名称 (英語) Method for promoting immune response comprising inhibiting CD22 function in B cells
発明の概要(英語) (US9018245)
The purpose of the present invention is to elucidate a relationship between deregulation of signaling by CD22 and a rapid response of B cells by IgG-BCR and the like, and to provide a method capable of inducing a rapid immune response and defending against infection instead of vaccine.
The present invention relates to a method for promoting an immune response causing such a strong proliferation of clones and production of a large amount of antibody-producing cells as those seen in the memory immune response even in the naive B cells expressing IgM-BCR and IgD-BCR by inhibiting the CD22 function in B cells; and to a method for screening a substance capable of promoting the immune response based on a change in the CD22 function in B cells.
特許請求の範囲(英語) [claim1]
1. A method of screening for a substance inhibiting that inhibits CD22 expression, comprising: (a) contacting said substance with cultured IgM or IgD positive naive B cells;
(b) measuring CD22 expression in said naïve B cells following said contacting step;
(c) comparing CD22 expression in step (b) with CD22 expression in control IgM or IgD positive naïve B cells; and
(d) determining whether said substance inhibits CD22 expression in said cultured IgM or IgD positive naive B cells relative to the control naïve B cells; and
(e) selecting the substance as a substance that promotes an early stage immune response based on said inhibition of CD22 expression in said cultured IgM or IgD positive naïve B cells relative to the control naïve B cells.
[claim2]
2. The method according to claim 1, wherein the method further comprises the step of measuring proliferation or survival of said B cells.
[claim3]
3. The method according to claim 1, wherein the method further comprises the step of treating the cells with an antigen.
[claim4]
4. The method according to claim 1, wherein the B cells are from a mouse.
[claim5]
5. The method according to claim 1, wherein the B cells are from a human.
  • 発明者/出願人(英語)
  • TSUBATA TAKESHI
  • ONODERA TAISHI
  • JAPAN SCIENCE AND TECHNOLOGY AGENCY
国際特許分類(IPC)
参考情報 (研究プロジェクト等) CREST Clarification of the Biological Functions of Sugar Chains and the Use of this Knowledge in Applied Technologies AREA
ライセンスをご希望の方、特許の内容に興味を持たれた方は、問合せボタンを押してください。

PAGE TOP

close
close
close
close
close
close